Comment on: Disentangling the association between retinal non-perfusion and anti-VEGF agents in diabetic retinopathy
- PMID: 34616003
- PMCID: PMC9307818
- DOI: 10.1038/s41433-021-01800-x
Comment on: Disentangling the association between retinal non-perfusion and anti-VEGF agents in diabetic retinopathy
Conflict of interest statement
The authors declare no competing interests.
Comment on
-
Disentangling the association between retinal non-perfusion and anti-VEGF agents in diabetic retinopathy.Eye (Lond). 2022 Apr;36(4):692-703. doi: 10.1038/s41433-021-01750-4. Epub 2021 Aug 18. Eye (Lond). 2022. PMID: 34408316 Free PMC article. Review.
References
-
- Elnahry AG, Abdel-Kader AA, Habib AE, Elnahry GA, Raafat KA, Elrakhawy K. Review on Recent Trials Evaluating the Effect of Intravitreal Injections of Anti-VEGF Agents on the Macular Perfusion of Diabetic Patients with Diabetic Macular Edema. Rev Recent Clin Trials. 2020;15:188–98. doi: 10.2174/1574887115666200519073704. - DOI - PMC - PubMed
-
- Alagorie AR, Nittala MG, Velaga S, Zhou B, Rusakevich AM, Wykoff CC, et al. Association of Intravitreal Aflibercept With Optical Coherence Tomography Angiography Vessel Density in Patients With Proliferative Diabetic Retinopathy: A Secondary Analysis of a Randomized Clinical Trial. JAMA Ophthalmol. 2020;138:851–7. doi: 10.1001/jamaophthalmol.2020.2130. - DOI - PMC - PubMed
-
- Sorour OA, Elsheikh M, Chen S, Elnahry AG, Baumal CR, Pramil V, et al. Mean macular intercapillary area in eyes with diabetic macular oedema after anti-vascular endothelial growth factor therapy and its association with treatment response. Clin Exp Ophthalmol. 2021;49:714–23. doi: 10.1111/ceo.13966. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
